• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单剂量及重复给药单胺氧化酶抑制剂对大鼠听觉惊吓反应的影响。

The effects of single and repeated administration of MAO inhibitors on acoustic startle response in rats.

作者信息

Zajaczkowski W, Górka Z

机构信息

Institute of Pharmacology, Polish Academy of Sciences, Kraków.

出版信息

Pol J Pharmacol. 1993 Mar-Apr;45(2):157-66.

PMID:8401768
Abstract

In this paper the effects of single and repeated administration of brofaromine (BRO) and moclobemide (MOC)--monoamine oxidase A (MAO-A) inhibitors as well as deprenyl (DEP)--monoamine oxidase B (MAO-B) inhibitor on behavior of rats in acoustic startle response test were studied. For comparison the tricyclic antidepressant amitriptyline (AMI) was also studied. BRO given in a single dose of 10 mg/kg diminished the amplitude of acoustic startle response, while in a dose of 30 mg/kg had no effect. MOC diminished the amplitude when given in a single dose of 30 mg/kg, and had no effect in a dose of 10 mg/kg. Both MAO type A inhibitors diminished the startle reaction amplitude when tested 2 h after the last dose of a repeated treatment (twice daily for 14 days, 10 or 30 mg/kg, po). 5 days after the last dose the treatments did not affect the response. DEP given both in a single dose of 0.25 mg/kg and repeatedly for 15 and 21 days, increased the amplitude of startle reaction immediately after completion of the treatment. 9 days after drug withdrawal this effect was not observed. DEP in a dose of 1.0 mg/kg had no effect on the amplitude of startle reaction in any experiments described above. The above results demonstrate that MAO-A inhibitors--brofaromine and moclobemide and a MAO-B inhibitor--deprenyl show opposit activity in acoustic startle response test. BRO and MOC exert the inhibitory activity, whereas DEP has an excitatory effect on the startle reaction. The reference drug, AMI had no effect when given in a single doses (2 and 10 mg/kg, po). After repeated treatment (twice daily for 14 days, 2 or 10 mg/kg, po), AMI diminished the amplitude of the startle reaction only in higher dose when tested 2 h after the last dose and had no effect in the experiment carried out 5 days after the last dose.

摘要

本文研究了单胺氧化酶A(MAO - A)抑制剂溴法罗明(BRO)和吗氯贝胺(MOC)以及单胺氧化酶B(MAO - B)抑制剂司来吉兰(DEP)单次及重复给药对大鼠听觉惊吓反应试验行为的影响。为作比较,还研究了三环类抗抑郁药阿米替林(AMI)。单次给予10mg/kg的BRO可降低听觉惊吓反应的幅度,而30mg/kg剂量则无作用。单次给予30mg/kg的MOC可降低幅度,10mg/kg剂量则无作用。两种MAO - A抑制剂在重复治疗(每日两次,共14天,10或30mg/kg,口服)最后一剂后2小时测试时均降低了惊吓反应幅度。最后一剂后5天进行的试验中,这些治疗均未影响反应。单次给予0.25mg/kg以及重复给药15天和21天的DEP,在治疗结束后立即增加了惊吓反应幅度。停药9天后未观察到该效应。1.0mg/kg剂量的DEP在上述任何实验中对惊吓反应幅度均无作用。上述结果表明,MAO - A抑制剂——溴法罗明和吗氯贝胺以及MAO - B抑制剂——司来吉兰在听觉惊吓反应试验中表现出相反的活性。BRO和MOC发挥抑制活性,而DEP对惊吓反应有兴奋作用。参比药物AMI单次给药(2和10mg/kg,口服)时无作用。重复治疗(每日两次,共14天,2或10mg/kg,口服)后,AMI仅在最后一剂后2小时测试时较高剂量下降低了惊吓反应幅度,在最后一剂后5天进行的实验中无作用。

相似文献

1
The effects of single and repeated administration of MAO inhibitors on acoustic startle response in rats.单剂量及重复给药单胺氧化酶抑制剂对大鼠听觉惊吓反应的影响。
Pol J Pharmacol. 1993 Mar-Apr;45(2):157-66.
2
Some central effects of brofaromine given repeatedly are phase-dependent.反复给予溴法罗明的一些中枢效应具有时相依赖性。
Pol J Pharmacol Pharm. 1990 Jul-Aug;42(4):313-20.
3
Light-dark phase differences in behavioral effects of moclobemide in rats.
Pol J Pharmacol Pharm. 1991 May-Jun;43(3):177-86.
4
The effect of imipramine after single and repeated administration on the apomorphine response in the acoustic startle reflex in rats.
Pol J Pharmacol Pharm. 1992 Jul-Aug;44(4):347-53.
5
Comparison of behavioral effects of moclobemide and deprenyl during forced swimming.吗氯贝胺与司来吉兰在强迫游泳期间行为效应的比较。
Pharmacol Biochem Behav. 1998 Jun;60(2):431-7. doi: 10.1016/s0091-3057(98)00011-2.
6
[Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice].[新型单胺氧化酶-A抑制剂吗氯贝胺、溴法罗明和托洛沙酮与反苯环丙胺在动物实验中的比较:对临床实践的意义]
Psychiatr Prax. 1989 Aug;16 Suppl 1:18-24.
7
The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromine.新一代单胺氧化酶抑制剂抗抑郁药的出现:吗氯贝胺和溴法罗明的药理学研究
Clin Neuropharmacol. 1993;16 Suppl 2:S1-7.
8
Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.促肾上腺皮质激素释放因子对两种大鼠品系听觉惊跳反应前脉冲抑制的影响。
Psychopharmacology (Berl). 2002 May;161(3):296-303. doi: 10.1007/s00213-002-1025-2. Epub 2002 Mar 28.
9
E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.E2011,一种新型、选择性且可逆的A型单胺氧化酶抑制剂。
J Pharmacol Exp Ther. 1996 Jul;278(1):243-51.
10
Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.单胺氧化酶-A抑制剂与大鼠尾状核中的多巴胺代谢:体内多巴胺胞质水平升高可取代可逆性单胺氧化酶-A抑制剂的证据。
J Pharmacol Exp Ther. 1993 Apr;265(1):103-11.

引用本文的文献

1
Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.司来吉兰的抗氧化和抗凋亡作用可预防 3-NP 诱导的大鼠神经毒性。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Sep;390(9):905-917. doi: 10.1007/s00210-017-1392-1. Epub 2017 Jun 23.
2
Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.青少年HIV-1转基因大鼠:甲基苯丙胺激发揭示行为和神经化学中多巴胺能改变的证据。
Curr HIV Res. 2012 Jul;10(5):415-24. doi: 10.2174/157016212802138788.
3
Chronic administration of imipramine normalizes decreased sexual motivation and increased predisposition to catalepsy induced by propylthiouracil in rats.
Neurosci Behav Physiol. 2009 May;39(4):409-15. doi: 10.1007/s11055-009-9134-6. Epub 2009 Apr 2.